The University of British Columbia’s School of Biomedical Engineering (SBME) recently announced the launch of a new educational offering, the Micro-certificate in Innovation Leadership: Medical & Bio-Innovations. The Academy of Translational Medicine is excited to share its involvement in the conception and development of this new educational offering, which will be delivered by SBME.
The part-time blended program addresses the gap between scientific and technological innovations and the practical, legal, and strategic skills needed to bring these innovations to market successfully. Developed by leading industry experts, the curriculum emphasizes the practical applications of innovation leadership and intellectual property management. Participants will gain an in-depth understanding of how to identify and address unmet medical needs, implement effective intellectual property strategies, and lead innovation projects within their organizations.
This program wouldn’t have been possible without the incredible support and insights from our industry advisory committee and partners at the UBC Academy of Translational Medicine and UBC Extended Learning. – SBME on LinkedIn
The Micro-certificate has been highly anticipated, receiving praise by trailblazers in the sector. Complementing the strong technical and scientific expertise that participants already possess, the program will bridge the gap to successfully bring medical and bio-innovations to market. As a stepping stone towards a future certificate in translational readiness, the ATM is pleased to share this new program with its Community, in addition to the ATM-led Regulatory Affairs in the Life Sciences Micro-credentials.
Courses in the Micro-certificate
- Intellectual Property (IP) Strategy and Management
- Unmet Needs in Healthcare: Strategy and Solutions
Information Session: 26 June 2024 | 12pm
Registration is open for the first cohort of the Micro-certificate in Innovation Leadership: Medical & Bio-Innovations, which will begin October 2024.